Date:
Federal regulators have made a significant decision regarding the labeling of certain weight loss medications. The U.S. Food and Drug Administration (FDA) has instructed drugmakers Novo Nordisk and Eli Lilly to remove warnings about potential suicidal thoughts and behaviors from their popular weight loss drugs. This move comes after a comprehensive review found no increased risk of suicide among users of these medications.
At Flux Bulletin, we cover a wide range of topics including business, politics, technology, education, health, sports, entertainment, crime, local news, and weather. Our goal is to provide balanced coverage that goes beyond the headlines, offering context and perspective that help you understand not just what is happening, but why it matters.
Subscribe to get our latest news delivered straight to your inbox.
© Copyright 2025. All Right Reserved By Fluxbulletin.com
